Global Hip and Joint Supplement Market Outlook, In‑Depth Analysis & Forecast to 2031

1.1 Introduction to Hip and Joint Supplement: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Hip and Joint Supplement Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Biscuits

1.2.3 Soft Treats

1.2.4 Chewable Tablets

1.2.5 Others

1.3 Market Segmentation by Application

1.3.1 Global Hip and Joint Supplement Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Pet Dog

1.3.3 Pet Cat

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2.1 Global Hip and Joint Supplement Revenue Estimates and Forecasts 2020-2031

2.2 Global Hip and Joint Supplement Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Hip and Joint Supplement Sales Estimates and Forecasts 2020-2031

2.4 Global Hip and Joint Supplement Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3.1 Global Hip and Joint Supplement Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2020-2025)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

3.2 Global Hip and Joint Supplement Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

3.3.2 Manufacturer-Level Price Trends (2020-2025)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Main Product Type Market Size by Manufacturers

3.5.1 Biscuits Market Size by Manufacturers

3.5.2 Soft Treats Market Size by Manufacturers

3.5.3 Chewable Tablets Market Size by Manufacturers

3.5.4 Others Market Size by Manufacturers

3.6 Global Hip and Joint Supplement Market Concentration and Dynamics

3.6.1 Global Market Concentration (CR5 and HHI)

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4.1 Global Hip and Joint Supplement Sales Performance by Type

4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

4.1.2 Global Sales Market Share by Type (2020-2031)

4.2 Global Hip and Joint Supplement Revenue Trends by Type

4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.2.2 Global Revenue Market Share by Type (2020-2031)

4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

4.4 Product Technology Differentiation

4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.5.1 High-Growth Niches and Adoption Drivers

4.5.2 Profitability Hotspots and Cost Drivers

4.5.3 Substitution Threats

5.1 Global Hip and Joint Supplement Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

5.1.2 Global Sales Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global Hip and Joint Supplement Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.2.2 Revenue Market Share by Application (2020-2031)

5.3 Global Pricing Dynamics by Application (2020-2031)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

6.1 North America Sales Volume and Revenue (2020-2031)

6.2 North America Key Manufacturers Sales Revenue in 2024

6.3 North America Hip and Joint Supplement Sales and Revenue by Type (2020-2031)

6.4 North America Hip and Joint Supplement Sales and Revenue by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Hip and Joint Supplement Market Size by Country

6.6.1 North America Revenue by Country

6.6.2 North America Sales Trends by Country

6.6.3 US

6.6.4 Canada

6.6.5 Mexico

7.1 Europe Sales Volume and Revenue (2020-2031)

7.2 Europe Key Manufacturers Sales Revenue in 2024

7.3 Europe Hip and Joint Supplement Sales and Revenue by Type (2020-2031)

7.4 Europe Hip and Joint Supplement Sales and Revenue by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Hip and Joint Supplement Market Size by Country

7.6.1 Europe Revenue by Country

7.6.2 Europe Sales Trends by Country

7.6.3 Germany

7.6.4 France

7.6.5 U.K.

7.6.6 Italy

7.6.7 Russia

8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

8.3 Asia-Pacific Hip and Joint Supplement Sales and Revenue by Type (2020-2031)

8.4 Asia-Pacific Hip and Joint Supplement Sales and Revenue by Application (2020-2031)

8.5 Asia-Pacific Hip and Joint Supplement Market Size by Region

8.5.1 Asia-Pacific Revenue by Region

8.5.2 Asia-Pacific Sales Trends by Region

8.6 Asia-Pacific Growth Accelerators and Market Barriers

8.7 Southeast Asia

8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.8 China

8.9 Japan

8.10 South Korea

8.11 China Taiwan

8.12 India

9.1 Central and South America Sales Volume and Revenue (2020-2031)

9.2 Central and South America Key Manufacturers Sales Revenue in 2024

9.3 Central and South America Hip and Joint Supplement Sales and Revenue by Type (2020-2031)

9.4 Central and South America Hip and Joint Supplement Sales and Revenue by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Hip and Joint Supplement Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

10.3 Middle East and Africa Hip and Joint Supplement Sales and Revenue by Type (2020-2031)

10.4 Middle East and Africa Hip and Joint Supplement Sales and Revenue by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Hip and Joint Supplement Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Turkey

10.6.4 Egypt

10.6.5 South Africa

11.1 Mars

11.1.1 Mars Corporation Information

11.1.2 Mars Business Overview

11.1.3 Mars Hip and Joint Supplement Product Models, Descriptions and Specifications

11.1.4 Mars Hip and Joint Supplement Sales, Price, Revenue and Gross Margin (2020-2025)

11.1.5 Mars Hip and Joint Supplement Sales by Product in 2024

11.1.6 Mars Hip and Joint Supplement Sales by Application in 2024

11.1.7 Mars Hip and Joint Supplement Sales by Geographic Area in 2024

11.1.8 Mars Hip and Joint Supplement SWOT Analysis

11.1.9 Mars Recent Developments

11.2 Nestle Purina

11.2.1 Nestle Purina Corporation Information

11.2.2 Nestle Purina Business Overview

11.2.3 Nestle Purina Hip and Joint Supplement Product Models, Descriptions and Specifications

11.2.4 Nestle Purina Hip and Joint Supplement Sales, Price, Revenue and Gross Margin (2020-2025)

11.2.5 Nestle Purina Hip and Joint Supplement Sales by Product in 2024

11.2.6 Nestle Purina Hip and Joint Supplement Sales by Application in 2024

11.2.7 Nestle Purina Hip and Joint Supplement Sales by Geographic Area in 2024

11.2.8 Nestle Purina Hip and Joint Supplement SWOT Analysis

11.2.9 Nestle Purina Recent Developments

11.3 EverRoot

11.3.1 EverRoot Corporation Information

11.3.2 EverRoot Business Overview

11.3.3 EverRoot Hip and Joint Supplement Product Models, Descriptions and Specifications

11.3.4 EverRoot Hip and Joint Supplement Sales, Price, Revenue and Gross Margin (2020-2025)

11.3.5 EverRoot Hip and Joint Supplement Sales by Product in 2024

11.3.6 EverRoot Hip and Joint Supplement Sales by Application in 2024

11.3.7 EverRoot Hip and Joint Supplement Sales by Geographic Area in 2024

11.3.8 EverRoot Hip and Joint Supplement SWOT Analysis

11.3.9 EverRoot Recent Developments

11.4 Milk-Bone

11.4.1 Milk-Bone Corporation Information

11.4.2 Milk-Bone Business Overview

11.4.3 Milk-Bone Hip and Joint Supplement Product Models, Descriptions and Specifications

11.4.4 Milk-Bone Hip and Joint Supplement Sales, Price, Revenue and Gross Margin (2020-2025)

11.4.5 Milk-Bone Hip and Joint Supplement Sales by Product in 2024

11.4.6 Milk-Bone Hip and Joint Supplement Sales by Application in 2024

11.4.7 Milk-Bone Hip and Joint Supplement Sales by Geographic Area in 2024

11.4.8 Milk-Bone Hip and Joint Supplement SWOT Analysis

11.4.9 Milk-Bone Recent Developments

11.5 Blue Buffalo

11.5.1 Blue Buffalo Corporation Information

11.5.2 Blue Buffalo Business Overview

11.5.3 Blue Buffalo Hip and Joint Supplement Product Models, Descriptions and Specifications

11.5.4 Blue Buffalo Hip and Joint Supplement Sales, Price, Revenue and Gross Margin (2020-2025)

11.5.5 Blue Buffalo Hip and Joint Supplement Sales by Product in 2024

11.5.6 Blue Buffalo Hip and Joint Supplement Sales by Application in 2024

11.5.7 Blue Buffalo Hip and Joint Supplement Sales by Geographic Area in 2024

11.5.8 Blue Buffalo Hip and Joint Supplement SWOT Analysis

11.5.9 Blue Buffalo Recent Developments

11.6 VetIQ

11.6.1 VetIQ Corporation Information

11.6.2 VetIQ Business Overview

11.6.3 VetIQ Hip and Joint Supplement Product Models, Descriptions and Specifications

11.6.4 VetIQ Hip and Joint Supplement Sales, Price, Revenue and Gross Margin (2020-2025)

11.6.5 VetIQ Recent Developments

11.7 JPK Nutri

11.7.1 JPK Nutri Corporation Information

11.7.2 JPK Nutri Business Overview

11.7.3 JPK Nutri Hip and Joint Supplement Product Models, Descriptions and Specifications

11.7.4 JPK Nutri Hip and Joint Supplement Sales, Price, Revenue and Gross Margin (2020-2025)

11.7.5 JPK Nutri Recent Developments

11.8 maxxipaws

11.8.1 maxxipaws Corporation Information

11.8.2 maxxipaws Business Overview

11.8.3 maxxipaws Hip and Joint Supplement Product Models, Descriptions and Specifications

11.8.4 maxxipaws Hip and Joint Supplement Sales, Price, Revenue and Gross Margin (2020-2025)

11.8.5 maxxipaws Recent Developments

11.9 Unicharm

11.9.1 Unicharm Corporation Information

11.9.2 Unicharm Business Overview

11.9.3 Unicharm Hip and Joint Supplement Product Models, Descriptions and Specifications

11.9.4 Unicharm Hip and Joint Supplement Sales, Price, Revenue and Gross Margin (2020-2025)

11.9.5 Unicharm Recent Developments

11.10 OSCAR Pet Foods

11.10.1 OSCAR Pet Foods Corporation Information

11.10.2 OSCAR Pet Foods Business Overview

11.10.3 OSCAR Pet Foods Hip and Joint Supplement Product Models, Descriptions and Specifications

11.10.4 OSCAR Pet Foods Hip and Joint Supplement Sales, Price, Revenue and Gross Margin (2020-2025)

11.10.5 OSCAR Pet Foods Recent Developments

11.11 Affinity Petcare

11.11.1 Affinity Petcare Corporation Information

11.11.2 Affinity Petcare Business Overview

11.11.3 Affinity Petcare Hip and Joint Supplement Product Models, Descriptions and Specifications

11.11.4 Affinity Petcare Hip and Joint Supplement Sales, Price, Revenue and Gross Margin (2020-2025)

11.11.5 Affinity Petcare Recent Developments

11.12 MoonShine

11.12.1 MoonShine Corporation Information

11.12.2 MoonShine Business Overview

11.12.3 MoonShine Hip and Joint Supplement Product Models, Descriptions and Specifications

11.12.4 MoonShine Hip and Joint Supplement Sales, Price, Revenue and Gross Margin (2020-2025)

11.12.5 MoonShine Recent Developments

11.13 Yantai China Pet Foods

11.13.1 Yantai China Pet Foods Corporation Information

11.13.2 Yantai China Pet Foods Business Overview

11.13.3 Yantai China Pet Foods Hip and Joint Supplement Product Models, Descriptions and Specifications

11.13.4 Yantai China Pet Foods Hip and Joint Supplement Sales, Price, Revenue and Gross Margin (2020-2025)

11.13.5 Yantai China Pet Foods Recent Developments

11.14 GREENIES

11.14.1 GREENIES Corporation Information

11.14.2 GREENIES Business Overview

11.14.3 GREENIES Hip and Joint Supplement Product Models, Descriptions and Specifications

11.14.4 GREENIES Hip and Joint Supplement Sales, Price, Revenue and Gross Margin (2020-2025)

11.14.5 GREENIES Recent Developments

11.15 Wagg

11.15.1 Wagg Corporation Information

11.15.2 Wagg Business Overview

11.15.3 Wagg Hip and Joint Supplement Product Models, Descriptions and Specifications

11.15.4 Wagg Hip and Joint Supplement Sales, Price, Revenue and Gross Margin (2020-2025)

11.15.5 Wagg Recent Developments

11.16 Petpal Tech

11.16.1 Petpal Tech Corporation Information

11.16.2 Petpal Tech Business Overview

11.16.3 Petpal Tech Hip and Joint Supplement Product Models, Descriptions and Specifications

11.16.4 Petpal Tech Hip and Joint Supplement Sales, Price, Revenue and Gross Margin (2020-2025)

11.16.5 Petpal Tech Recent Developments

11.17 DogKind

11.17.1 DogKind Corporation Information

11.17.2 DogKind Business Overview

11.17.3 DogKind Hip and Joint Supplement Product Models, Descriptions and Specifications

11.17.4 DogKind Hip and Joint Supplement Sales, Price, Revenue and Gross Margin (2020-2025)

11.17.5 DogKind Recent Developments

11.18 Pet Treats

11.18.1 Pet Treats Corporation Information

11.18.2 Pet Treats Business Overview

11.18.3 Pet Treats Hip and Joint Supplement Product Models, Descriptions and Specifications

11.18.4 Pet Treats Hip and Joint Supplement Sales, Price, Revenue and Gross Margin (2020-2025)

11.18.5 Pet Treats Recent Developments

11.19 Pet Chews

11.19.1 Pet Chews Corporation Information

11.19.2 Pet Chews Business Overview

11.19.3 Pet Chews Hip and Joint Supplement Product Models, Descriptions and Specifications

11.19.4 Pet Chews Hip and Joint Supplement Sales, Price, Revenue and Gross Margin (2020-2025)

11.19.5 Pet Chews Recent Developments

12.1 Hip and Joint Supplement Industry Chain

12.2 Hip and Joint Supplement Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 Hip and Joint Supplement Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2020-2031)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 Hip and Joint Supplement Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details